Companies / Hungary
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Richter Given Go-Ahead For Polpharma Acquisition
July 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Hungary's Gedeon Richter has been given the green light from Poland's Office of Competition and Consumer Protection (OCCP) for the acquisition of Polish generics maker Polpharma. The decision, on July 4 2008, comes almost eight months after the deal was initially announced and will make Richter the leading pharmaceutical company in Central and Eastern Europe (CEE). The OCCP said the deal 'will not significantly limit competition, especially through the creation or strengthening of a market dominating